← FDA Drug Approvals (Drugs@FDA)

ENABLEX

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2004-12-22

Drug application

FDA Application #

NDA021513

Application type

New Drug Application

Brand name

ENABLEX

Generic name

Darifenacin Hydrobromide

Active ingredients

DARIFENACIN HYDROBROMIDE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

ABBVIE

First approval

2004-12-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown